How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Intragastric Balloon for Weight Loss Market
- By Balloon Type: Single Balloon Systems, Dual Balloon Systems, Adjustable Balloons, Swallowable Balloons
- By Procedure Setting: Outpatient Clinics, Hospitals, Ambulatory Surgical Centers
- By Patient Demographics: Adults with BMI 30-40 kg/m², Adults with BMI >40 kg/m², Patients with Obesity-Related Comorbidities
- By End-Use: Bariatric Clinics, Gastroenterology Centers, Weight Management Centers
- By Duration of Balloon Placement: Short-Term (Up to 6 months), Medium-Term (6-12 months), Long-Term (Over 12 months)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Single Balloon Systems leads By Balloon Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 284 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.172 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.180 →
Full report · locked preview
Everything inside the Intragastric Balloon for Weight Loss Market report
A complete, evidence-based study - 12 chapters and 119 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Balloon Type 4
Procedure Setting 3
Patient Demographics 3
End-Use 3
Duration of Balloon Placement 3
Companies profiled
Apollo Endosurgery Inc.
ReShape Lifesciences Inc.
Allurion Technologies
Obalon Therapeutics Inc.
Medtronic plc
GI Dynamics Inc.
Spatz Medical Inc.
Lexel Medical Ltd.
Endalis
HMS Holdings Corp.
BaroNova
Helioscopie
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Apollo Endosurgery Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →ReShape Lifesciences Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Allurion Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Obalon Therapeutics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →GI Dynamics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Spatz Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Lexel Medical Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Endalis
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →HMS Holdings Corp.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →BaroNova
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Helioscopie
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Bariatric Solutions
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →BioEnterics Corporation (a subsidiary of Allergan)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →EnteroMedics Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,371M by 2033 · 8.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Single Balloon Systems57.3
- Dual Balloon Systems18.0
- Adjustable Balloons11.8
- Swallowable Balloons12.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$414.7M → $778.7M · 8.2%
Europe$289.1M → $582.5M · 9.2%
Asia Pacific$263.9M → $446.6M · 6.8%
Latin America$163.4M → $282.6M · 7.1%
Middle East and Africa$125.7M → $213.1M · 6.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.222026
8.212027
8.242028
8.242029
8.262030
8.262031
8.272032
8.302033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Apollo Endosurgery Inc.15.7
- ReShape Lifesciences Inc.23.3
- Allurion Technologies11.8
- Obalon Therapeutics Inc.7.9
- Medtronic plc5.8
- GI Dynamics Inc.7.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Balloon Type21.7%
Procedure Setting23.0%
Patient Demographics12.7%
End-Use24.6%
Duration of Balloon Placement18.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.8
- Europe25.3
- Asia Pacific19.4
- Latin America12.3
- Middle East and Africa9.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Apollo Endosurgery Inc. | 98 | 93 | 93 | 98 | 89 | 81 | 92 |
| ReShape Lifesciences Inc. | 89 | 83 | 75 | 75 | 90 | 72 | 81 |
| Allurion Technologies | 72 | 81 | 76 | 80 | 76 | 76 | 77 |
| Obalon Therapeutics Inc. | 59 | 63 | 82 | 60 | 81 | 81 | 71 |
| Medtronic plc | 66 | 65 | 60 | 69 | 68 | 73 | 67 |
| GI Dynamics Inc. | 64 | 58 | 62 | 68 | 56 | 50 | 60 |
| Spatz Medical Inc. | 56 | 51 | 64 | 63 | 63 | 57 | 59 |
| Lexel Medical Ltd. | 47 | 57 | 56 | 55 | 60 | 44 | 53 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Apollo Endosurgery Inc.
- ReShape Lifesciences Inc.
- Allurion Technologies
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Apollo Endosurgery Inc. | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| ReShape Lifesciences Inc. | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Allurion Technologies | ✓ | ◐ | ✓ | ✓ | ✓ | ◐ |
| Obalon Therapeutics Inc. | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Medtronic plc | ◐ | ◐ | − | − | ✓ | ◐ |
| GI Dynamics Inc. | ◐ | ◐ | − | − | − | ◐ |
| Spatz Medical Inc. | − | − | ◐ | − | − | − |
| Lexel Medical Ltd. | − | ◐ | ◐ | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Apollo Endosurgery Inc.92
2ReShape Lifesciences Inc.81
3Allurion Technologies77
4Obalon Therapeutics Inc.71
5Medtronic plc67
6GI Dynamics Inc.60
7Spatz Medical Inc.59
8Lexel Medical Ltd.53
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Apollo Endosurgery Inc.ReShape Lifesciences Inc.
Challenger3
Strong scale, closing on the leaders.
Allurion TechnologiesObalon Therapeutics Inc.Medtronic plc
Contender2
Focused players with pockets of strength.
GI Dynamics Inc.Spatz Medical Inc.
Niche1
Specialists in a single segment or region.
Lexel Medical Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Balloon Type in North America, then scale across Intragastric Balloon for Weight Loss Market — a $322M beachhead inside a $4.72B market.
Beachhead (SOM)$322Mobtainable near-term
Serviceable (SAM)$1.93Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Single Balloon Systems
Best fit — highest urgency & budget in Balloon Type.
Economic buyer78 fit
Dual Balloon Systems
Strong fit — clear ROI and a fast path to value.
End user67 fit
Adjustable Balloons
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Balloon Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Procedure Setting & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Patient Demographics
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel27%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Balloon Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Intragastric Balloon for Weight Loss Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified24%
Evaluation13%
Closed-won6%
$10.6KCAC
$40KLTV
3.8:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Intragastric Balloon for Weight Loss Market is a durable-growth opportunity — $1.00B by 2033, compounding at 6.8%.
TAM · 2025$595Mtoday
TAM · 2033$1.00Bforecast
CAGR6.8%2027–2033
Cumulative$7.05Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.00BTotal addressable market
SAM$384MServiceable available market
SOM$70MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.8% CAGR
Demand compounds through 2033, outpacing GDP across Balloon Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Balloon Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.00BLarge & growingTAM by 2033 at 6.8% CAGR
$384MServiceable nowreachable with today’s model
$70MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$782MBear4.4% CAGR
$1.00BBase6.8% CAGR
$1.28BBull8.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Procedure Setting optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Intragastric Balloon for Weight Loss Market — a $5.90B market by 2033. Plan: grow share from 6.1% to 11.5%.
Market size · 2033$5.90Btotal addressable
Market CAGR3.5%2027–2033
Target share11.5%from 6.1% today
Revenue ambition$678Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.1% | 11.5% | On track |
| Revenue | $327M | $678M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 36.2% | 43.8% | Behind |
| Customer retention | 89.6% | 96.4% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Balloon Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Procedure Setting capability
A defensible second engine — invest in Procedure Setting to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Balloon Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Procedure Setting
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $91M capacity & capability investment
- Greenlight bolt-on M&A in Procedure Setting
- Authorise North America expansion plan
- Fund R&D program for Balloon Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Intragastric Balloon for Weight Loss Market conversation — a $4.49B market you can size, segment and defend in minutes.
Market size · 2033$4.49Btotal opportunity
Growth10.2%CAGR to 2033
Addressable buyers1,019+accounts in scope
Typical ROI6.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Balloon Type
Goal Grow share in Balloon Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.4×return on cost, year one
< 3 mopayback period
$57K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Apollo Endosurgery Inc.ReShape Lifesciences Inc.Allurion TechnologiesObalon Therapeutics Inc.Medtronic plcGI Dynamics Inc.Spatz Medical Inc.Lexel Medical Ltd.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Intragastric Balloon for Weight Loss Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Intragastric Balloon for Weight Loss Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Intradermal Injection Device Market
Market size, share, segmentation and regional forecast.
$571M market · 2025 base year
View reportIntradental-Intraosseous Implants Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportIntracranial Treatment Drug Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportIntracranial Thrombus Aspiration Catheter Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportIntracranial Thrombectomy Stent Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportIntracranial Therapeutic Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportIntracranial Support Catheter Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportIntracranial Stent System Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportIntracranial Stent Graft Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportIntracranial Stenosis Stents Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportIntracranial Pressure Non-Invasive Comprehensive Detection Analyzer Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportIntracranial Pressure Monitor Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.